Health Canada OKs research into popular morning-sickness drug
A gag order that stopped a drug researcher from sharing clinical data on leading drug Diclectin has been lifted
Canada’s not for sale. Maclean’s is. Subscribe today
Navindra Persaud
Future doctors demand boundaries with Big Pharma
Medical schools address conflict-of-interest